Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05561647 · ClinicalTrials.gov registry record
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
A clinical trial of Short Bowel Syndrome (SBS), sponsored by Takeda.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT05561647 is a study of Short Bowel Syndrome (SBS) that is actively recruiting participants, run by Takeda. The registered enrollment target is 600 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05561647, a study of Short Bowel Syndrome (SBS), is actively recruiting participants, sponsored by Takeda.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is about learning and documenting how well participants and physicians understand how to use GATTEX and about potential risks by using a survey (called Knowledge Assessment Survey). This survey, which is conducted every two years, is part of the Gattex Risk Evaluation and Mitigation Strategy (REMS). REMS is a safety program required by the US health authority (FDA) for certain medicines that have serious risks. REMS intends to help reduce these risks while still allowing treatment. The goal is to make sure these medicines are used in the safest way possible. The main aim of this survey is to find out how well participants and physicians understand the checkups and tests (so called monitoring) participants should have while taking GATTEX, and the possible risks or of using GATTEX to treat Short Bowel Syndrome. The knowledge assessment survey will be done via internet, telephone, or paper and both physicians and participants will be able to choose the method that is preferred. No study medicines will be provided to participants in this study.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
Massachusetts
- Takeda Pharmaceuticals, U.S.A., Inc. - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2013-08-01 |
| Est. Completion | 2031-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05561647
The ClinicalTrials.gov registry entry for NCT05561647 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Short Bowel Syndrome (SBS) appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT05561647 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05561647 about?
NCT05561647 is a clinical study titled "A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)". The study is about learning and documenting how well participants and physicians understand how to use GATTEX and about potential risks by using a survey (called Knowledge Assessment Survey). This survey, which is conducted every two years, is part of the Gattex Risk Evaluation and Mitigation Strate...
What is the current status of trial NCT05561647?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2013-08-01. Estimated completion is 2031-12-31.
What conditions does trial NCT05561647 study?
This clinical trial studies the following conditions: Short Bowel Syndrome (SBS).
What interventions are being tested in trial NCT05561647?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05561647?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05561647 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.